CamGene Therapeutics
Developer of nanoparticle-based mRNA therapeutic drugs designed for patients who have lost their hearing. The company's lipid nanoparticle-based mRNA technology precisely targets ear cells to deliver ...
Valuation
$8.8M
Latest known
Share Price
N/A
Total Raised
$4.9M
Last Round
N/A